Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Nov 1;42(5):476–484. doi: 10.1016/j.chnaes.2021.10.011

Cultural belief and medicinal plants in treating COVID 19 patients of Western Colombia

Leonomir Cordoba-Tovar a, Virleydys Ríos-Geovo b, MF Largacha-Viveros b, Manuel Salas-Moreno b, José Luis Marrugo-Negrete c, Pablo Andrés Ramos a, Lina Mosquera Chaverra b, MP Jonathan d,
PMCID: PMC8557979

Abstract

The main background of this study is that corona virus (COVID-19) has caused a global chaos where there was a complete lockdown of the whole planet as well as the collapse of the health system in many developed, developing and under-developed countries. This situation has caused a public health system and till date no decisive treatment is being confirmed so far. The present study from western Colombia focuses on the importance of traditional, cultural and generations history with reference to the use of importance and significance of medicinal plants, especially to find out a strategy to fight the new virus. The study was designed based on three major novel ethno-environmental strategies based on infusion, hot drinks, fresh baths and jelly types were identified. Based on the generated results, the calculated highest used species in the present pandemia indicates Zingiber officinale Roscoe (1.0), Eucalyptus globulus Labiil. (0.86), Citrus x limon (L.) Osbeck (0.80), Gliricidia sepium (Jacq.) Walp (0.56) and Matricaria recutita L. (0.52) were the species with the highest use. No significant difference was observed between men and women for the level of knowledge on these traditional medicinal plants. Moreover, many of the scientific information demonstrate their effectiveness in treating the respiratory infections caused due to the corona virus. The results infer the importance of traditional medicine, knowledge which needs more attention and research to counter attack the outbreak especially in medically weak health systems.

Keywords: COVID-19, Medicinal plants, Traditional knowledge, Usage level, Colombia

Abbreviations: E, Eucaliptus; HIV, Human immuno deficiency virus; MZ, Manzanilla; RPL, Relative Popularity Level of Plants; STU, Significant Tramil Use (STU); SUT, Significant Use of Tramil; WHO, World Health Organization

Graphical abstract

Unlabelled Image

1. Introduction

The new corona virus outbreak “COVID-19” is a respiratory disease that has affected the whole planet and it is recorded as one of the fastest spreading disease in the modern times with a high death rate (https://covid19.who.int). The disease was detected in late December 2019, but it gained attention World-wide during mid-March 2020 when the whole planet went into a complete lock down with all human movements stopped as per the advice of World Health Organization [1,2]. Specifically, the outbreak of the disease was traced to Wuhan, China in late 2019 early 2020 and it spread around exponentially in a roaring manner [3]. The most important symptoms are high fever, cough and fatigue and in the worst case it affected the respiratory system where the patient ultimately dies [4,5]. According to updated data on 2nd November, 2021, nearly 248,039,551 confirmed cases are reported world-wide and 5,024,445 persons have lost their lives due to this deadly pandemic (https://worldmeters.info/coronavirus/coronavirus-death-toll/). The main attraction in this pandemia is the mortality rate which prompted the scientific community go on a war footing in search of vaccines and medications that can stop the spread of the disease and most importantly to arrest the control the mortality rate [6].

In the present scenario, the interest in putting into practice on the traditional knowledge associated with the use of medicinal plants in particular as a strategy to mitigate the impacts of COVID-19 was identified [7,8]. Recent report indicates that in the world 390,000 plant species are identified, where approximately 60,000 have been exclusively used as medicinal plants and around 26,000 of those have direct scientific evidence and confirmed through cultural practice in different geographical regions [9,10]. More importantly, the use of medicinal plants and trade has raised in recent decades internationally with a net revenue that has tripled over time 1.3 (in 1998) to 3.3 billion USD (in 2018) [10]. The growth on use of the medicinal plants has responded very well recently to meet the economic challenge of many recently during the current pandemia [11].

1.1. Worldwide scenario

Recently, in China a study indicates that the Radix glycyrrhizae rhizome [12,13] is an option that is important for its healing properties. Moreover, according to Chinese guidelines it can be used as a guide for treatment of COVID-19 patients. However, it is still in clinical process to produce the evidences [14,15]. Another specific case that attracts the attention of plants, is the amount of amino acids (121) that these lectin (griffithsin) contains which are produced by the red algae of the genus Griffithsia. This also acted as an inhibitory agent for many viruses including the HIV virus, ebola virus and some corona viruses [14,16]. On a world-wide scenario, plant species like Myristica fatua Houtt, Glycyrrhiza glabra L. and Psidium guajava L. was used to control the spread of the deadly virus dengue, influenza (H1N1) and HIV respectively [[17], [18], [19], [20]]. Moreover, important diseases like diabetics and obesity has been treated with Salvia leucantha Cav., liver based problems with Cymbopogon citratus (DC.) Stapf [21,22]. Based on historical evidences, the plants open up important possibilities to efficiently control the COVID-19 pandemic in the absence of effective regular treatments [6]. Hence the importance of rescuing the society and in managing the economy during the health emergency period can be directly linked to the concept of “socio-environmental intelligence”.

The main aim of this study is to describe the role of cultural belief, society, its contribution with the use of medicinal plants to counteract the health emergency. This was done where a balance was achieved in the local community through knowledge, sensitiveness and behavioral act of humans which contributed to find some sought of remedial measures in the Western Colombia. In addition, other purpose of the study was to evaluate the level of knowledge between men and women considering the number of plants reported by each participant.

2. Materials and methods

2.1. Patient search and data generation

Based on experience and with reference to the subject to assess the relevance of the study, a survey was applied using the Google Drive tool and a general questionnaire was prepared and distributed to patients with possible symptoms in the Chocó Department of Western Colombia during June/July 2020 (Fig. 1). The questionnaire was distributed in two different manner: 1) through emails and 2) through whatsup messages as these are the widely used online messaging softwares/ programs used in this region of Colombia. The questionnaire was focused on just six different easy enquiry which brought out the answers for: 1) Place of residence; 2) Gender; 3) What are medicinal plants he/ she used during the COVID-19 treatment; 4) How & ways of using the medicinal plants; 5) How they got the recipe for treating the COVID-19 virus and 6) Did you or have any symptoms associated with COVID-19 patients? (Supplementary Table T1). Moreover, the participation in this survey was made as voluntary without restriction of racial ethnicity, age, gender or sexual orientation [7]. The whole survey was applied in the Colombian Pacific region which has traditional history of knowledge of medicinal plants dominated by the Afro-Colombian race community people. In addition, the purpose of the study was to know the level of knowledge for local men/women who are considering or using the medicinal plants for the treatment of the COVID-19 virus. The survey was closed as soon as it reached a total of one hundred participants (n = 100) (Supplementary Table T2). The number of participants was also not pre-fixed, but due to the low response of participants the response was very low and it was decided to close the questionnaire, which was also statistically sufficient for any general analysis. Moreover, based on ethnobiological concepts has been applied in the present study and due to the present limitations 100 participants has only been presented [23].

Fig. 1.

Fig. 1

Study area map of Western Colombia, Colombia.

The plants used during the treatment were recognized by photographs and the description of the diagnostic characteristics of the participants. The plants were also identified using the list of plants (https://www.theplantlist.org) and the virtual herbarium of the Universidad Nacional de Colombia (https://www.biovirtual.unal.edu.co/nombrecomunes/en) were consulted to corroborate scientific names assigned to each species [24,25]. Herbarium data information was extracted from the already published data and was compared with the ethnobotanical data [25]. In addition, the plant species was also identified based on the herbarium list in Universidad Tecnológica del Choco, Colombia in Department of Choco, Colombia, which was validated with all available scientific names. The whole data was organized based on genus and species as categorized along with the WHO International Classification of Diseases 10, where the mode of application, parts used and mode of application was recorded [26].

2.2. Type and approach of study

The present study was approached in a mixed way which was focused on ways to measure the qualitative and quantitative variables of data collection on usage of medicinal plants. This was done based on the information related to traditional knowledge associated with the use of medicinal plants during this time of pandemic. Mostly, the native and introduced plants were included for the analysis [27] and the formulas associated with industrial drugs were rejected because it was not considered as an ethnobotanical study.

2.3. Data analysis

The collected information was tabulated in an Excel spreadsheet and was purified until obtaining the necessary information for our analysis. The use value index that refers to the importance of use that a given species has according to its reporting frequency in the sampling was applied and is obtained through the following process explained in Eq. (1).

UVis=species frequency,ismaximum value of the most used species (1)

Where, UV is the use of value index of the species usage. The maximum value is calculated by the most species used that obtained the highest report in the entire individual sample (i.e the most used). Moreover, it can be a same species or a different species. The UVis varies between 0 and 1, where 1 being the species with higher values which is highly sought for and used regularly. Significant differences were evaluated between men and women with respect to the level of knowledge in relation to the number of plants reported through a t-student test (0.05) [28].

Additionally, the relative popularity level of each species was determined to assess its sociocultural importance applying the formula below (Eq. (2)) [29]. The level of significant tramil use (STU) that values a species with frequencies greater than or equal to 20% is a subject of scientific validation. This is calculated by dividing the number of use or citation of species by the number of respondents surveyed (Eq. (3)) [30].

RPL=nifn (2)

Where, nif is equal to the number of informants citing the species, and n equal to the total number of informants.

SUT=speciessnis×100 (3)

Where, use of species (s) is equal to the number of citations for each species and (nis) number of people surveyed.

2.4. Patient evidences

In a direct attempt to understand the use of medicinal plants, direct interviews were video recorded on the experience undergone during the treatment and only willing COVID-19 patients who wished to share the direct evidence of the process involved in using the traditional medicinal plants are presented in this study.

3. Results

3.1. Botanical composition and use value

Based on the results from the questionnaire the results generated in this study are presented based on botanical importance and its use with reference to cultural heritage.

The list yielded a total of 37 plant species comprised 22 families and 32 genus. Two of the species were unidentified in the present group. The families best represented by the number of species were Lamiaceae with seven species (19%) and Verbenaceae (8%). The other families were represented by one to seven species respectively (Fig. 2 ). According to the use during the COVID-19 treatment process the following species obtained the highest use values within the various mixtures: Zingiber officinale (1.0), Eucalyptus globulus (0.86), Gliricidia sepium (0.56), Citrus x limon (0.80) and Matricaria recutita (0.52) (Table 1 ). Based on the Pearson's correlation analysis, the results indicate a positive linear relationship (r 2 = 1, p < 0.01) between the values that identifies the difference indexes of sociocultural importance and the number of citations of the species within a particular sample (Fig. 3 ).

Fig. 2.

Fig. 2

Distribution of botanical families by number of species. Lamiaceae encompasses a significant number of species with high potential and applicability in the pharmaceutical industry because they have chemical compounds capable of inhibiting microbial activities.

Table 1.

Quantitative analysis of medicinal species used in the prevention and treatment of COVID-19.

Sl.Nos. Local name
(in Spanish)
Local name
(in English)
Families Scientific name n UV RPL SUL
1 Ajo Garlic Amarilidaceae Allium sativum L. 7 0.14 0.07 2.57
2 Albahaca Basil Lamiaceae Ocimum sp 2 0.04 0.02 0.74
3 Amaranto Amaranth Amaranthaceae Amaranthus sp 1 0.02 0.01 0.37
4 Anamú Phytolacaceae Petiveria alliacea L. 1 0.02 0.01 0.37
5 Apio Celery Apiaceae Apium graveolens L. 2 0.04 0.02 0.74
6 Canela Cinnamon Lauraceae Cinnamomum verum J.Presl 2 0.04 0.02 0.74
7 Cebolla morada Red Onion Amarilidaceae Allium cepa L. 2 0.04 0.02 0.74
8 Celedonia Piperaceae Peperomia pellucida Kunth 2 0.04 0.02 0.74
9 Cien piecito UI UI 1 0.02 0.01 0.37
10 Cilantro Coriander Apiaceae Eryngium foetidum L. 1 0.02 0.01 0.37
11 Coca UI UI 1 0.02 0.01 0.37
12 Cúrcuma Zingiberaceae Curcuma longa L. 2 0.04 0.02 0.74
13 Espabonilla Gesneriaceae Glossloma panamense (C.V. Morton) J.L. Clark 1 0.02 0.01 0.37
14 Eucaliptus Eucalyptus Myrtaceae Eucalyptus globulus Labill. 43 0.86 0.43 15.81
15 Galve Fabaceae Senna reticulata (Willd.) H.S.Irwin & Barneby 1 0.02 0.01 0.37
16 Guácimo Malvaceae Luehea seemannii Triana & Planch 1 0.02 0.01 0.37
17 Hierbabuena Peppermint Lamiaceae Mentha x piperita L. 4 0.08 0.04 1.47
18 Jengibre Ginger Zingiberaceae Zingiber officinale Roscoe 50 1.0 0.5 18.38
19 Limón Lemon Rutaceae Citrus x limon (L.) Osbeck 40 0.80 0.4 14.71
20 Limoncillo Lemongrass Poaceae Cymbopogon citratus (DC.) Stapf 14 0.28 0.14 5.15
21 Llantén Plantaginacea Plantago major L. 1 0.02 0.01 0.37
22 Manzanilla Chamomile Asteraceae Matricaria recutita L. 26 0.52 0.26 9.56
23 Matarratón Fabaceae Gliricidia sepium (Jacq.) Walp. 28 0.56 0.28 10.29
24 Menta Mint Lamiaceae Mentha rotundifolia (L.) Huds. 1 0.02 0.01 0.37
25 Moringa Moringaceae Moringa olifera Lam. 5 0.1 0.05 1.84
26 Naranja Orange Rutaceae Citrus x aurantium L. 4 0.08 0.04 1.47
27 Orégano Lamiaceae Origanum vulgare L. 3 0.06 0.03 1.10
28 Orozul Verbenaceae Phyla dulcis (Trevir.) Moldenke 1 0.02 0.01 0.37
29 Paíco Chenopodiaceae Chenopodium ambrosioides L. 1 0.02 0.01 0.37
30 Poleo Lamiaceae Clinopodium brownei (Sw.) Kuntze 1 0.02 0.01 0.37
31 Prontoalivio Soon-relief Verbenaceae Lippia alba (Mill.) N.E.Br. ex Britton & P.Wilson 5 0.1 0.05 1.84
32 Romero Lamiaceae Rosmarinus officinalis L. 2 0.04 0.02 0.74
33 Santamaría Piperaceae Piper peltatum L. 1 0.02 0.01 0.37
34 Sauco Solanaceae Solanum sp 12 0.24 0.12 4.41
35 Siempreviva Commelinaceae Tripogandra serrulata (Vahl) Handlos 1 0.02 0.01 0.37
36 Toronjil Lemon balm Lamiaceae Melissa officinalis L. 1 0.02 0.01 0.37
37 Verbena Verbenaceae Stachytarpheta cayennensis (Rich.) Vahl 1 0.02 0.01 0.37

n = citations number; UV: use value; RPL: relative popularity level; SUL: significant usage level (tramil); UI: Unidentified.

= species with greater value of use and cultural acceptance (>20%). These potential plants are recommended as per the government guidelines for the treatment of covid-19.

Fig. 3.

Fig. 3

a–c Linear relationship between the values that a species takes in the different indexes of sociocultural importance based on the number of citations within the sample. The number of informants has an important incidence when it comes to quantitatively evaluating the uses of plants.

3.2. Traditional knowledge

Based on the results, the participants were divided into 75 women and 25 men. The t sudden test (men n = 25, 2.420 ± 1.782 and women n = 75, 2.947 ± 1.902; p > 0.005) indicates that there are no statistically significant differences between men and women regarding the level of knowledge of medicinal plants used for treatments by different patients. The differences among the use of species is measured from the number of plants reported by each participant.

The thirty-seven species, three different patterns of formulas associated with the treatment of COVID-19 were identified. They were seen as: infusion / or hot drinks (56%), cool bath (33%) and jelly/ or syrup (11%). According to the information reported by the participants, the acquisition of the botanical formulas obtained were of the following order: Cultural beliefs (64%) > Recommended (24%) Other (7%) > Acquired from internet (5%) respectively (Suppl. Fig. 1).

Overall, 19 persons reported having been infected with the disease and have described in detail on how they used the medicinal plants the formulas they adopted during the treatment process (Table 2 ). The main observation in the formulas documented were accounted as cooked (various medicinal plants), fresh bathing (using leafs), mixing the aromatics with lemon (to drink), fermented drinks (based on different mixtures) and inhalations (steam vapor generation).

Table 2.

Medicinal formulas for the treatment of COVID-19 and participants account.

Plant codes Mixing formula used
E The leaves are cooked and taken in hot aromatics and infusion
MZ The plant is cooked and lemon juice is added and it is taken hot
PCS Several leaves are cooked, lemon is added and it is drunk in hot aromatics
AMG Leaves are cooked and fresh baths are given from head to toe
MT Leaves are crushed in water, then strained and fresh baths are prepared
JLE Cook a piece of the rhizome, add lemon to taste and drink hot
AC Crush several cloves of garlic, chop the onion, then mix and take a tablespoon three times a day
NLCJMZ Three oranges, four lemons, two cinnamon sticks, a fist of chamomile, a piece of ginger are squeezed, then all the ingredients are cooked in two liters of water and taken hot in the mornings and nights
HA The leaves are cooked and taken in hot aromatics and infusion
JEMZLI In a liter of boiling water, add three centimeters of ginger, three cross-cut lemons, seven lemongrass leaves, add honey and drink hot
MGSES The leaves are crushed in water and left to serene for a day. Then fresh baths are given for after days in the mornings, then several days are allowed to pass and the elderberry with santamaria is added. Subsequently, hot drinks and infusion of garlic, lemon, ginger, lemongrass are taken during the treatment
EJ 1/4 of panela, a piece of ginger rhizome, a crushed garlic clove, onion juice, lemon and chamomile juice and zest, boil the ingredients for half an hour. Then inhalations are made and a cup is taken three times a day for a week

Code: E = Eucaliptus; MZ = Manzanilla; PCS = Prontoalivio + Celedonia + Sauco; AMG = Anamú + Matarratón + Guácimo; MT = Matarratón; JLE = Jengibre + Limón + Eucaliptus; AC = Ajo + Cebolla; NLCJMZ = Naranja + Limon + Canela + Jengibre + Manzanilla; HA = Hierbabuena + Albahaca; JEMZLI = Jengibre + Eucaliptus + Manzanilla + Limoncillo; MTGSES = Matarratón + Galve + Sauco + Espabonilla; EJ = Eucaliptus + Jengibre. (Note: Do not drink hot drinks during treatment.)

4. Discussion

The traditional knowledge associated with medicinal plants nowadays is taking on wide spread importance worldwide, possibly due to the appearance of the new disease of COVID-19 [13]. Traditional medicine reveals the exclusivity of many plants used for the treatment based on health problems. During these treatments, notable differences are observed between one botanical family and another based on its distribution and sociocultural importance [31,32].

4.1. Importance of species in medicinal use

Importance of some species has to be taken into account as some of them have often significantly reached the applicability in the pharmaceutical industries [31,33].

One important species family that played a role in the present pandemia is Lamiaceae where genus Rosmarinus [34], Occimun sp., [35,36] and Mentha sp., dominated the general usage (Fig. 2). Lamiaceae for example is one of the families with a wide distribution throughout the world with at least 200 genus and 4000 species many of them are medicinal [32,37]. This also makes it as one of the representative families in the diversity of the medicinal plants around the world [38,39] with special socio-cultural importance to the Afro-descendant communities located in this region. Additionally, the curative effectiveness is attributed to the contents of carnosic acid, carnosol, betulinic acid, camphor and rosmarinic acid [33,40,41] and phenolic compounds, di- and triterpenes and essential oils [42]. These components have the ability to inhibit actions of microorganisms harmful to human health [43].

During the present treatment process, mostly C. citratus (Lemongrass) was used as an ancestral medicine in communities of this region and this is well supported by its use in the southwest Asian countries [44]. Its healing potential is attributed to the presence of essential oils which includes terpenes, alcohol esters, aldehydes and ketones [21,45]. Likewise, Z. officinale one of the most valued species in the chocoano tropic in the midst of the pandemia currently has a high demand for use and commercialization, mainly due to the effectiveness in the treatment of COVID-19 patients as evidenced in the present study. Its rhizome represents an importance in food and in practical medicine which is linked to the transfer of traditional knowledge from generation to generation [46]. Phytochemical reactions during the treatment process indicate its effectiveness which is related to the presence of monoterpene and sequiterpenic hydrocarbon content especially α-zingiberene, ar-curcumene, β-bisabolene and β-sesquiphellandrene [47,48].

Glircidia sepium is another species which is being widely used during the present pandemia (Table 1). The phytochemical potential is related to the concentration of phenol (1.7 mg/ml) and flavonoids (0.46 mg/ml), in addition the alkaloid and saponins contents have the power to inhibit infectious microorganisms [49]. Other observations report a value of 3.94 mg/g of flavonoids, which makes this species an important resource to alleviate health problems caused by pathogens [50]. The species continues to be promising in ehtnomedicine and biomedicine because twelve important bioactive compounds are currently presumed to be present to address health problems [51,52]. Recent studies report the natural phytoconstituents (alliin, ajoenes, flavonoids, allicin and vinyldtithines) of A. sativum decrease the expression of proinflammatory cytokines and strengthen the immune system, where it becomes a very useful resource to counteract COVID-19 virus infections [53,54].

4.2. Popularity of medicinal plants based

Based on the acceptance of medicinal plant in the recent treatment process the following plants ranked higher in the order based on the significant usage level (only reported upto above 1%): Ginger (18.8) > Ecalyptus (15.81) > Lemon (14.71) > Matarratón (in spanish) (10.29) > Chamomile (9.56) > Lemon grass (5.15) > Sauco (in spanish) (4.41) > Garlic (2.57) > Moringa (in spanish) (1.84) ≥ Prontoalivio (in Spanish) (1.84) > Orange (1.47) ≥ Peppermint (1.47) > Orégano (1.10) respectively (Table 1).

Twelve distinct medicinal formulas were reported by various respondents and the results have been documented to understand the usage way in which, traditional, cultural generational practices played a role in treating the COVID-19 virus (Table 2; Video 1).

Generally, the leaves were cooked and taken along with hot aromatics and infusion (Code: E = Eucaliptus). In some cases, the plant is cooked and lemon juice is added to be taken hot (Code: MZ = Manzanilla). Several leaves (Prontoalivio + Celedonia + Sauco) (Anamú + Matarraton + Guácimo) were cooked garden-fresh and fresh baths were given morning/evening two times a day (Code: PCS, AMG, MT). Rhizome pieces were taken along with lemon as hot liquid (Code: JLE). Likewise, cloves of garlic, onion chop are crushed and mixed for ingestion thrice a day (morning/evening) (Code: AC).

In some of the cases, large volumes of oranges, lemons, cinnamon sticks, chamomile, ginger were all cooked together and taken hot in morning and night time (Code: NLCJMZ). A combination of hierbabuena and albahaca was cooked and mixed with hot aromatics and taken (Code: HA). In boiling water, ginger, cross-cut lemons, lemongrass were mixed with honey and drunk hot (Code: JEMZLI). A combination of leaves (matarratón, galve, sauco, espabonilla) was crushed and left (soaked) for a complete day, then in the subsequent days, daily morning baths are given based on this water (Code: MGSES). Inhalations were made through boiling water vaopur where panela, ginger rhizome, garlic, clove, onion juice, lemon, chamomile juice were boiled and it was taken for a week continuously (Code: EJ) [55].

5. Human evidences and the application

Based on the questionnaire and information collected, nine patients are presented as evidences through direct interviews (Video 1). The information has been translated from the native Spanish language used in this region. All the patients presented as evidences were tested positive for COVID-19 and they have shared their knowledge on the use of medicinal plants and the particular formulas used based on their cultural traditional knowledge. The results on the confirmation of COVID-19 positive test by most of the patients has been reported by the Institute for National Health, Colombia.

5.1. Importance of ethnobotanical study

Ethnobotanical studies have increased widely during the present COVID-19 pandemia especially in underdeveloped and smaller countries [56]. This type of treatment process confirms that medicinal plants are one of the alternatives to prevent, treat and halt the spread of COVID-19 virus [13]. Moreover, the knowledge associated with medicinal plants can lead to the development of environmental awareness to face future challenges on human health [57]. However, many studies are required to help validate the effectiveness of these medicinal plants [58]. In the present situation, government guidelines can be advanced to promote public health policies linked to traditional medicine (based on medicinal plants) that can save some live around the world [9,56]. In addition, computational (in silico) studies, drug repurposing and genetic engineering will be a good ally in finding a safe and effective treatment against COVID-19 [59].

6. Historical evidences on use of medicinal plants

Historical evidences evaluated during the 20th and 21st century suggest that during various pandemic, the medicinal plants have played a role in the treatment process before the arrival of major vaccine (Supplementary Table T3).

In the 20th century 1957–58 “Asian Flu” outbreak, species like Garlic Red, Spider lily, and la equinaceae was used. During the 1960´s when the “Dengue virus” arrived various species related to Papaya, Mint, Eucalyptus, Lemon grass, Mat grass were widely [60] used. In the 21st century “Influenza (H1N1)” virus spread during 2009–10 various evidences of Elder, Garlic Red, Spider Lily, Coconut, Chamomile, Eupatoria, La Equinaceae, Mint, Tulsi, Guduchi, Eucalytus, Yashtimadhu, Indian Goose berry, were used [[61], [62], [63], [64], [65]]. In the “Ebola virus” season during 2013 Tabaco, Benthi was the only reported species used [66,67]. In 2015 season during the spread of “Zika virus” Garlic Red, Coconut, Chamomile, Pina, Papaya and limon was used [[68], [69], [70], [71]].

Recently during the COVID-19 spread, till date the use of Garlic Red, Spider Lily, Chamomile, Eucalyptus, limon, Mat grass, Ginger, Jengibre has been reported through various interviews. Commonly, in the present scenario during the ongoing pandemia the common medicinal plants which are popular in medically weak country like Colombia are: garlic, chamomile, eucalyptus, lemongrass, lemon, soon-relief, curcuma and ginger [72]. This is very well supported by the four principal medicinal plants with strong pharmacological activity in garlic, which is rich in sulfur containing phytoconstituents such as allicin, ajoenes, vinyldithiins and flavonoids such as quercetin [55,75]. Likewise, ginger has the primary agents like phenylalklketones or Vanillyl ketones [73]. Presence of 1,8-cineole, spathulenol, α-terpineol, α-pinene, limonene, tricyclene, camphene, globulol, ο-cimene, cisocymene, α-terpinyl acetate, ρ-cymene, β-myrcene, solanone, β-pinene, α-pinene, ο-cymene, limonene, 1,8-cineole in E. globulus (eucalyptus) does contain strong pharmacological activity [74]. High contents of phenolic compounds mainly flavonoids (eg. Diosmin, hesperdin, limocitrin) and phenolic acids (eg. Ferulic, synaptic, p-hydroxybenzoic acids) are present in lemon [75]. The extracts are directly related to the treatments like antibacterial, antiviral, antifungal, anti-inflammatory, antiparastic, respiratory diseases, common cold and sinus congestion problems [[76], [77], [78], [79], [80]].

7. Conclusion

The results generated from this cultural and traditional based study for treating COVID-19 patients justify the role of society and how it has been helpful in counteracting the outbreak to some extent. Generally, the study also suggests the commonly used plants that garlic, ginger, eucalyptus, lemon, lemon grass, chamomile and papaya were used during most of the pandemia that has spread during the 20th and 21st centuries. The plants were used in different mixtures in diverse conditions and considerable recovery has also been attained mostly in the rural regions (during different pandemia) which are strongly based on ethinic and cultural values.

However, phytochemical studies are also recommended and it needs to be validated for the efficacy of the chemical components not only from the popular plants, but also from the species that are invisible in the scientific world. The results also justify the need on the importance to improve the research on ethno-cultural knowledge and the significance of medicinal plants in treating various patients in under developed and medically weak countries worldwide which will often save many human lives.

The following are the supplementary data related to this article.

Supplementary Fig. F1.

Supplementary Fig. F1

Frequency and ways of using plants. Plants were grouped into three large groups of formulas. Infusion and hot drinks = (2 + 3 + 4 + 6 + 7 + 8 + 9 + 19 + 20 + 21 + 24 + 27 + 28 + 29 + 26 + 10 + 11 + 12 + 13 + 14 + 16 + 17 + 18 + 32 + 30 + 33 + 34 + 35 + 36) = hot drinks are made in panela water or made only in water. Panela or honey is also added and inhalations are made during the night and in the morning. In some cases they are taken as ordinary water. Fresh baths (1 + 5 + 15 + 22 + 23 + 25) = macerate and head-to-toe baths to control body temperature. Jelly (31 + 37) = the leaves are crushed and honey is added to it and one tablespoon is taken three times a day.

Supplementary Table T1

Traditional knowledge questionnaire on use of medicinal plants for COVID-19 treatments from western Colombia region.

mmc2.docx (140.4KB, docx)
Supplementary Table T2

General history and information of medicinal plants used by patients who participated in the present study in Western Colombian region, Colombia.

mmc3.docx (29.4KB, docx)
Supplementary Table T3

Historical data on use of medicinal plants for treating important diseases during the past 50 years.

mmc4.docx (34KB, docx)
Video 1

Direct video evidences on experiences of COVID-19 patients on use of medicinal plant and its preparation.

Download video file (136.4MB, mp4)

Ethical approval

This article does not contain any studies with human samples (only direct interviews) performed by the authors.

Declaration of Competing Interest

The authors declare no conflict of interest.

Acknowledgments

Acknowledgement

The local help provided by each participants are greatly appreciated. LCT thanks the doctoral research scholarship (Bicentennial) granted by the Ministry of Science, Technology and Innovation (MINCIENCIAS, Colombia), and the Faculty of Environmental and Rural Studies (PUJ, Colombia) and the Natural Resources and Environmental Toxicology Research Group (UTCH, Colombia). MPJ thanks Sistema Nacional de Investigadores, CONACyT and Instituto Politécnico Nacional (EDI and COFAA), México. This article is 119th contribution (partial) from the Earth System Science Group (ESSG), Mexico and Chennai, India (Participating member: MPJ).

References

  • 1.World Health Organization (WHO) WHO Director-General's Opening Remarks at the Media Briefing on COVID-19. 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---6-april-2020 Accessed, June 25, 2020.
  • 2.World Health Organization (WHO) WHO Coronavirus Disease (COVID-19) Dashboard. 2020. https://covid19.who.int/https://covid19.who.int/ Accessed, 4 Jul, 2020.
  • 3.Munster V.J., Koopmans M., van Doremalen N., van Riel D., de Wit E. A novel coronavirus emerging in China - key questions for impact assessment. New England J. Med. 2020;382(8):692–694. doi: 10.1056/NEJMp2000929. [DOI] [PubMed] [Google Scholar]
  • 4.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Stower H. Virological assessment of SARS-CoV-2. Nat. Med. 2020;26:465. doi: 10.1038/s41591-020-0848-x. [DOI] [PubMed] [Google Scholar]
  • 6.Capell T., Twyman R.M., Armario-Najera V., Ma J.K.C., Schillberg S., Christou P. Potential applications of plant biotechnology against SARS-CoV-2. Trends Plant Sci. 2020;25(7):635–643. doi: 10.1016/j.tplants.2020.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Li Y., Liu X., Guo L., Li J., Zhong D., Zhang Y., Clarke M., Jin R. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis. Syst. Rev. 2020;9(1):1–6. doi: 10.1186/s13643-020-01343-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ren J.-L., Zhang A.H., Wang X.J. Traditional Chinese medicine for COVID-19 treatment. Pharm. Res. 2020;155:104743. doi: 10.1016/j.phrs.2020.104743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Paredes R., Hopkins A.L., Villanueva F. Ethnobotany in the north coast of Peru: use of plants in the fishing community of huanchaco for subsistence. Econ. Botany, Camino. 1992;2020:1–14. [Google Scholar]
  • 10.Timoshyna A., Ling X., Leaman D. The invisible trade will plants and you in the times of COVID-19 and essential journey towards sustainability. Invisible Trade. 2020:1–12. https://www.traffic.org/publications/reports/the-invisible-trade-wild-plants-and-you-in-the-time-of-covid-19/ [Google Scholar]
  • 11.Afonso A.F., Pereira O.R., Fernandes Â., Calhelha R.C., Silva A.M.S., Ferreira R.C.F., Cardoso S.M. Phytochemical composition and bioactive effects of Salvia africana, salvia officinalis “Icterina” and Salvia mexicana aqueous extracts. Molecules. 2019;24(23):1–13. doi: 10.3390/molecules24234327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Jiang J., Xiao S., Yan S., Xiao J., Xu X. Glycyrrhizae Radix et Rhizoma processed by sulfur fumigation damaged the chemical profile accompanied by immune suppression and liver injury. Biomed. Res. Int. 2020:5439853. doi: 10.1155/2020/5439853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Luo H., Tang Q., Shang Y., Liang S., Yang M., Nicola R., Jian J. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chinese J. Int. med. 2020:1–8. doi: 10.1007/s11655-020-3192-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ang L., Lee H.W., Kim A., Lee J.A., Zhang J., Lee M.S. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Int. Med. Res. 2020;9:100407. doi: 10.1016/j.imr.2020.100407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yang Z., Wang M., Zhu Z., Liu Y. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review. J. Mat.-Fetal Neonatal. Med. 2020 doi: 10.1080/14767058.2020.1759541. [DOI] [PubMed] [Google Scholar]
  • 16.Mori T., O'Keefe B.R., Sowder R.C., Bringans S., Gardella R., Berg S., Cochran P., Turpin J.A., Buckheit R.W., McMahon J.B., Boyd M.R. Isolation and characterization of Griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem. 2005;280(10):9345–9353. doi: 10.1074/jbc.M411122200. [DOI] [PubMed] [Google Scholar]
  • 17.Anywar G., Kakudidi E., Byamukama R., Mukonzo J., Schubert A., Oryem-Origa H. Data on medicinal plants used by herbalists for boosting immunity in people living with HIV/AIDS in Uganda. Eur. J. Int. Med. 2020;29:105097. doi: 10.1016/j.dib.2019.105097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Arora R., Chawla R., Marwah R., Arora P., Sharma R.K., Kaushik V., Goel R., Kaur A., Silambarasan M., Tripathi R.P., Bhardwaj J.R. Potential of complementary and alternative medicine in preventive management of novel H1N1 flu (swine flu) pandemic: thwarting potential disasters in the bud. Evid. Based Complement. Alternat. Med. 2011;2011:2–16. doi: 10.1155/2011/586506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rosmalena R., Elya B., Dewi B.E., Fithriyah F., Desti H., Angelina M., Hanafi M., Lotulung P.D., Prasasty V.D., Seto D. The antiviral effect of Indonesian medicinal plant extracts against dengue virus in vitro and in silico. Pathogens. 2019;8(2):1–11. doi: 10.3390/pathogens8020085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Torabian G., Valtchev P., Adil Q., Dehghani F. Anti-influenza activity of elderberry (Sambucus nigra) J. Funct. Foods. 2019;54:353–360. [Google Scholar]
  • 21.Ekpenyong C., Akpan E., Nyoh A. Ethnopharmacology, phytochemistry, and biological activities of Cymbopogon citratus (DC.) Stapf extracts. Chin. J. Nat. Med. 2015;13(5):321–337. doi: 10.1016/S1875-5364(15)30023-6. [DOI] [PubMed] [Google Scholar]
  • 22.Pereira O.R., Catarino M.D., Afonso A.F., Silva A.M.S., Cardoso S.M. Salvia elegans, salvia greggii and salvia officinalis decoctions: antioxidant activities and inhibition of carbohydrate and lipid metabolic enzymes. Molecules. 2018;23(12):3169. doi: 10.3390/molecules23123169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Albuquerque U.P., Ramos M.A., de Lucena R.F.P., Alencar N.L. In: Methods and Techniques in Ethnobiology and Ethnoecology. Springer Protocols Handbooks. Albuquerque U., Cruz da Cunha L., de Lucena R., Alves R., editors. Humana Press; New York, NY: 2014. Methods and techniques used to collect ethnobiological data. [Google Scholar]
  • 24.Hoffman B., Gallaher T. Importance indices in ethnobotany. Ethnobot. Res. Appl. 2007;5:201–218. [Google Scholar]
  • 25.Nesbitt M. In: Curating Biocultural Collections: A Hand Book. Salick J., Konchar K., Nesbitt M., editors. Vol. 22. Kew Publs; Chap: 2014. Use of herbarium specimens in ethnobotany; pp. 313–328. [Google Scholar]
  • 26.World Health Organization . 2016. World Health Statistics 2016. Monitoring Health for the SDGs; p. 136. [Google Scholar]
  • 27.Albuquerque U., Lucena R., Monteiro J., Florentino A., de Fatima C. Evaluating two quantitative ethnobotanical echniques. Ethnobot. Res. Appl. 2006;4(1):51–60. [Google Scholar]
  • 28.Valois-Cuesta H., Martínez-Ruiz C., Rentería Cuesta Y.Y., Panesso Hinestroza S.M. Diversidad, patrones de uso y conservación de palmas (Arecaceae) en bosques pluviales del Chocó, Colombia. Rev de Biol. Trop. 2013;61(4):1869–1889. [PubMed] [Google Scholar]
  • 29.Friedman J., Yaniv Z., Dafni A., Palewitch D. A preliminary classification of the healing potential of medicinal plants, based on a rational analysis of an ethnopharmacological field survey among Bedouins in the Negev Desert, Israel. J. Ethnopharmacol. 1986;16:275–287. doi: 10.1016/0378-8741(86)90094-2. [DOI] [PubMed] [Google Scholar]
  • 30.Germosén-Robineau L. Hacia una Farmacopea Caribeña. TRAMIL 4: investigación científica y uso popular de las plantas medicinales en el Caribe (Université) 1995. http://www.manioc.org/recherch/T17003
  • 31.Gras A., Serrasolses G., Vallès J., Garnatje T. Traditional knowledge in semi-rural close to industrial areas: ethnobotanical studies in western Gironès (Catalonia, Iberian Peninsula) J. Ethnobiol. Ethnomed. 2019;15(1):1–37. doi: 10.1186/s13002-019-0295-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hedge C. In: Adv. In labiate Sci. Royal Bot. Gardens. Harley R., Reynolds T., editors. 06. 1992. A global survey of the biogeography of the labiatae; pp. 7–17. (11) [Google Scholar]
  • 33.Andrade J., Célia F., Garcia C., Ladeiras D., Reis C., Rijo P. Rosmarinus officinalis L.: an update review of its phytochemistry and biological activity. Future Sci. 2018;4(4):1–11. doi: 10.4155/fsoa-2017-0124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Elansary H.O., Mahmoud E.A., Shokralla S., Yessoufou K. Diversity of plants, traditional knowledge, and practices in local cosmetics: a case study from Alexandria. Egypt. Econ. Bot. 2015;69(2):114–126. [Google Scholar]
  • 35.Aburigal Y.A.A., Hamza N.B., Hussein I.H., Elmogtaba E.Y., Osman T.H., Ali F.I., Siribel A.A.M. Variability in content and chemical constituents of essential oil of sweet basil (Ocimum basilicum L.) obtained from aerial plant parts. Adv. Biosci. Biotechnol. 2016;7(3):183–187. [Google Scholar]
  • 36.Albuquerque U., Andrade L. Etnobotanica del genero Ocimun L (Lamiaceae) en las comunidades afrobrasileñas. Anales Jardin Bot. de Madrid. 1992;56(1):107–118. [Google Scholar]
  • 37.Uritu C.M., Mihai C.T., Stanciu G.D., Dodi G., Alexa-Stratulat T., Luca A., Leon-Constantin M.M., Stefanescu R., Bild V., Melnic S., Tamba B. Medicinal plants of the family Lamiaceae in pain therapy: a review. Pain Res. Manag. 2018;7801543:44. doi: 10.1155/2018/7801543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Farooq S., Barki A., Yousaf M., Faal H. Ethnobotanical studies of the flora of tehsil birmal in south waziristan agency, Pakistan. Weed Sci. Res. 2012;18(3):277–291. [Google Scholar]
  • 39.Ullah M., Khan M.U., Mahmood A., Malik R.N., Hussain M., Wazir S.M., Daud M., Shinwari Z.K. An ethnobotanical survey of indigenous medicinal plants in Wana district South Waziristan agency, Pakistan. J. Ethnopharmacol. 2013;150(3):918–924. doi: 10.1016/j.jep.2013.09.032. [DOI] [PubMed] [Google Scholar]
  • 40.Begum A., Sandhya S., Ali S.S., Vinod K.R., Reddy S., Banji D. An in-depth review on the medicinal flora Rosmarinus officinalis (Lamiaceae) Acta Sci. Polonorum. Tech. Aliment. 2013;12(1):61–73. [PubMed] [Google Scholar]
  • 41.Ulbricht C., Abrams T.R., Brigham A., Ceurvels J., Clubb J., Curtiss W., Kirkwood C.D., Giese N., Hoehn K., Iovin R., Isaac R., Rusie E., Serrano J.M.G., Varghese M., Weissner W., Windsor R.C. An evidence-based systematic review of rosemary (Rosmarinus officinalis) by the natural standard research collaboration. J. Diet Suppl. 2010;7(4):351–413. doi: 10.3109/19390211.2010.525049. [DOI] [PubMed] [Google Scholar]
  • 42.Aumeeruddy-Elalfi Z., Gurib-Fakim A., Mahomoodally M.F. In: Antibiotic Resistance: Mechanisms and New Antimicrobial Approaches. Kon K., Rai M., editors. Vol. 6. 2016. Antimicrobial and antibiotic potentiating activity of essential oils from tropical medicinal herbs and spices; pp. 271–289. [Google Scholar]
  • 43.Nakagawa S., Hillebrand G.G., Nunez G. Rosmarinus officinalis l. (rosemary) extracts containing carnosic acid and carnosol are potent quorum sensing inhibitors of staphylococcus aureus virulence. Antibio. 2020;9(4):149. doi: 10.3390/antibiotics9040149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Shah G., Shri R., Panchal V., Sharma N., Singh B., Mann A.S. Scientific basis for the therapeutic use of Cymbopogon citratus, stapf (Lemon grass) J. Adv. Pharm. Tech. & Res. 2011;2(1):3–8. doi: 10.4103/2231-4040.79796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Uchida N.S., Silva-Filho S.E., Aguiar R.P., Wiirzler L.A.M., Cardia G.F.E., Cavalcante H.A.O., Silva-Comar F.M.D.S., Becker T.C.A., Silva E.L., Bersani-Amado C.A., Cuman R.K.N. Protective effect of cymbopogon citratus essential oil in experimental model of acetaminophen-induced liver injury. Amer. J. Chinese Med. 2017;45(3):515–532. doi: 10.1142/S0192415X17500318. [DOI] [PubMed] [Google Scholar]
  • 46.Salgado F. Giger (Zingiber officinale) Revista Int. de Acupuntura. 2011;5:167–173. [Google Scholar]
  • 47.Sharifi-Rad M., Varoni E.M., Salehi B., Sharifi-Rad J., Matthews K.R., Ayatollahi S.A., Kobarfard F., Ibrahim S.A., Mnayer D., Zakaria Z.A., Sharifi-Rad M., Yousaf Z., Iriti M., Basile A., Rigano D. Plants of the genus zingiber as a source of bioactive phytochemicals: from tradition to pharmacy. Molecules. 2017;22(12):1–20. doi: 10.3390/molecules22122145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sivasothy Y., Chong W.K., Hamid A., Eldeen I.M., Sulaiman S.F., Awang K. Essential oils of Zingiber officinale var. rubrum Theilade and their antibacterial activities. Food Chem. 2011;124(2):514–517. [Google Scholar]
  • 49.Akharaiyi F.C., Boboye B., Adetuyi F.C. Antibacterial, phytochemical and antioxidant activities of the leaf extracts of Gliricidia sepium and Spathodea campanulata. World Appl. Sci. J. 2012;16(4):523–530. [Google Scholar]
  • 50.Kolawole O.M., Joseph A.K., George O.A. Antibacterial and phytochemical activity of Gliricidia sepium against poultry pathogens. Microbiol. Res. J. Int. 2018;24(4):1–10. [Google Scholar]
  • 51.Abdulaziz A.A., Dapar M.L.G., Aranas A.T., Mindo R.A.R., Cabrido C.K., Manting M.M.E., Torres M.A., Demayo C.G. Qualitative evaluation of the antimicrobial, antioxidant, and medicinally important phytochemical constituents of the ethanolic extracts of the leaves of Gliricidia sepium (Jacq.) Walp. Pharmacophore. 2019;10(4):72–83. [Google Scholar]
  • 52.Vimalanathan S., Kang L., Treyvaud Amiguet V., Livesey J., Arnason J.T., Hudson J. Echinacea purpurea aerial parts contain multiple antiviral compounds. Pharm. Biol. 2005;43:740–745. [Google Scholar]
  • 53.Batiha G.E.S., Beshbishy A.M., Wasef L.G., Elewa Y.H.A., Al-Sagan A., El-Hack M.E.A., Taha A.E., Abd-Elhakim Y.M., Devkota H.P. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): a review. Nutrients. 2020;12(3):2–21. doi: 10.3390/nu12030872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Donma M.M., Donma O. The effects of allium sativum on immunity within the scope of COVID-19 infection. Med. Hypotheses. 2020;144:2–5. doi: 10.1016/j.mehy.2020.109934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Yingsakmongkon S., Miyamoto D., Sriwilaijaroen N., Fujita K., Matsumoto K., Jampangern W., Hiramatsu H., Guo C.T., Sawada T., Takahashi T., Hidari K., Suzuki T., Ito M., Ito Y., Suzuki Y. In vitro inhibition of human influenza A virus infection by fruit-juice concentrate of Japanese plum (Prunus mume Sieb. Et Zucc) Biol. Pharm. Bull. 2008;31(3):511–515. doi: 10.1248/bpb.31.511. [DOI] [PubMed] [Google Scholar]
  • 56.Xu J., Zhang Y. Traditional Chinese medicine treatment of COVID-19. Compl. Therap Clin. Pract. 2020;39:1–2. doi: 10.1016/j.ctcp.2020.101165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Jasmine T., Sundaram R.M., Poojitha M., Swarnalatha G., Padmaja J., Rupesh Kumar M., Reddy K.B. Medicinal properties of Gliricidia sepium: a review. Int. J. Curr. Phar. Clin. Res. 2017;7(1):35–39. [Google Scholar]
  • 58.Zhang D.-H., Wu K.L., Zhang X., Deng S.Q., Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integ. Med. 2020;18(2):152–158. doi: 10.1016/j.joim.2020.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Khan S.A., Al-Balushi K. Combating COVID-19: the role of drug repurposing and medicinal plants. J. Infect. Public Health. 2021;14:495–503. doi: 10.1016/j.jiph.2020.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ahmad N., Fazal H., Ayaz M., Abbasi B.H., Mohammad I., Fazal L. Dengue fever treatment with Carica papaya leaves extracts. Asian Pac. J. Trop. Biomed. 2011;1(4):330–333. doi: 10.1016/S2221-1691(11)60055-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Arnau J.V. Tratamientos naturales para la gripe aviar o gripe A. 2020. https://www.enbuenasmanos.com/tratamientos-naturales-para-la-gripe-aviar Accessed, July 25, 2020.
  • 62.Cech N.B., Kandhi V., Davis J.M., Hamilton A., Eads D., Laster S.M. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE2 from RAW 264.7 macrophage-like cells. Int. Immuno Pharmacol. 2010;10(10):1268–1278. doi: 10.1016/j.intimp.2010.07.009. [DOI] [PubMed] [Google Scholar]
  • 63.Czeranko S. Naturopathic Doctor News & Review. 2018. Un siglo despúes de la gripe española.https://ndnr.com/nature-cure/a-century-after-the-spanish-flu/ Accessed, July 25, 2020. [Google Scholar]
  • 64.Dao T.T., Nguyen P.H., Won H.K., Kim E.H., Park J., Won B.Y., Oh W.K. Curcuminoids from Curcuma longa and their inhibitory activities on influenza a neuraminidases. Food Chem. 2012;134(1):21–28. [Google Scholar]
  • 65.Wirotesangthong M., Nagai T., Yamada H., Amnuoypol S., Mungmee C. Effects of Clinacanthus siamensis leaf extract on influenza virus infection. Microbiol. Immunol. 2009;53(2):66–74. doi: 10.1111/j.1348-0421.2008.00095.x. [DOI] [PubMed] [Google Scholar]
  • 66.Plantguy How Anti-Ebola Drugs Are Produced In Plants …. And Why. 2014. https://www.howplantswork.com/2014/11/23/how-anti-ebola-drugs-are-produced-in-plants-and-why/ Accessed, July 27, 2020.
  • 67.Phoolcharoen W., Bhoo S.H., Lai H., Ma J., Arntzen C.J., Chen Q., Mason H.S. Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. Plant Biotechnol. J. 2011;9(7):807–816. doi: 10.1111/j.1467-7652.2011.00593.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.APHRC (Ayurvedic Panchakarma Hospital and Research Centre) Herbal Cure For ZIKA VIRUS Infection, cure zika infection naturally, ayurvedic treatment for zika, herbs for zika virus, viral infection, immunity boosting herbs. 2008. http://www.ayurvedahimachal.com/index.php?page=completearticle&&id=143#sthash.3UNH45X0.WWjaydWE.dpbs Accessed, July 25, 2020.
  • 69.Chen S., Evans T. Newsroom Plant-Derived Drug Shows Powerful Ability to Eliminate Zika Virus Infection from Brain Cells. 2017. https://news.weill.cornell.edu/news/2017/07/plant-derived-drug-shows-powerful-ability-to-eliminate-zika-virus-infection-from-brain Accessed, July 25, 2020.
  • 70.Sharma V. Homeopathic Medicines for Zika Virus Treatment and Prevention. 2020. https://www.drhomeo.com/fever/homeopathic-medicines-for-zika-virus-treatment-and-prevention/ Accessed, July 25, 2020.
  • 71.Tai Y., Ling C., Wang C., Wang H., Su L., Yang L., Jiang W., Yu X., Zheng L., Feng Z., Liu C., Yuan Y. Analysis of terpenoid biosynthesis pathways in German chamomile (Matricaria recutita) and Roman chamomile (Chamaemelum nobile) based on co-expression networks. Genomics. 2020;112(2):1055–1064. doi: 10.1016/j.ygeno.2019.10.023. [DOI] [PubMed] [Google Scholar]
  • 72.Garcia S., Sarmiento P. Análisis De La Medición De La Inteligencia Ambiental En Empresas Del Sector Lácteo En Bogotá. Bol. Semillas Amb. 2017;11(2):109–117. [Google Scholar]
  • 73.Mishra R.K., Kumar A., Kumar A. Pharmacological activity of Zingiber officinale. Int. J. Pharm. Chem. Sci. 2012;1(3):1073–1078. [Google Scholar]
  • 74.Salehi B., Sharifi-Rad J., Quispe C., Llaique H., Villalobos M., Smeriglio A., Trombetta D., Ezzat S.M., Salem M.A., Zayed A., Castillo C.M.S., Yazdi S.E., Sen S., Acharya K., Sharopov F., Martins N. Insights into Eucalyptus genus chemical constituents, biological activities and health promoting effects. Trends Food Sci. Technol. 2019;91:609–624. [Google Scholar]
  • 75.Klimek-Szczykutowicz M., Szopa A., Ekiert H. Citrus Limon (lemon) phenomenon—a review of the chemistry, pharmacological properties, applications in the modern pharmaceutical, food, and cosmetics industries, and biotechnological studies. Plants. 2020;9:119. doi: 10.3390/plants9010119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Hudson J., Vimalanathan S., Kang L., Amiguet V.T., Livesey J., Arnason J.T. Characterization of antiviral activities in Echinacea root preparations. Pharm. Biol. 2005;43:790–796. [Google Scholar]
  • 77.Kaushik S., Kaushik S., Sharma V., Parkash J. Pharmacognosy reviews. Pharmacol. Rev. 2018;12:177–185. [Google Scholar]
  • 78.Mochida K. Anti-influenza virus activity of Myrica rubra leaf ethanol extract evaluated using Madino-Darby canine kidney (MDCK) cells. Biosci. Biotechnol. Biochem. 2008;72(11):3018–3020. doi: 10.1271/bbb.80330. [DOI] [PubMed] [Google Scholar]
  • 79.Nagai T., Moriguchi R., Suzuki Y., Tomimori T., Yamada H. Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis. Antivir. Res. 1995;26(1):11–25. doi: 10.1016/0166-3542(94)00062-d. [DOI] [PubMed] [Google Scholar]
  • 80.Ooi L.S.M., Tian L., Su M., Ho W.S., Sun S.S.M., Chung H.Y., Wong H.N.C., Ooi V.E.C. Isolation, characterization, molecular cloning and modeling of a new lipid transfer protein with antiviral and antiproliferative activities from Narcissus tazetta. Peptides. 2008;29(12):2101–2109. doi: 10.1016/j.peptides.2008.08.020. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Table T1

Traditional knowledge questionnaire on use of medicinal plants for COVID-19 treatments from western Colombia region.

mmc2.docx (140.4KB, docx)
Supplementary Table T2

General history and information of medicinal plants used by patients who participated in the present study in Western Colombian region, Colombia.

mmc3.docx (29.4KB, docx)
Supplementary Table T3

Historical data on use of medicinal plants for treating important diseases during the past 50 years.

mmc4.docx (34KB, docx)
Video 1

Direct video evidences on experiences of COVID-19 patients on use of medicinal plant and its preparation.

Download video file (136.4MB, mp4)

Articles from Acta Ecologica Sinica are provided here courtesy of Elsevier

RESOURCES